Anoro Ellipta Articles
Elan pays $1 billion for a 21% share of Theravance royalties on four respiratory programs
13 May 2013
GSK pays $7.5 million milestone to Isis Pharma under antisense deal; says FDA accepts Anoro Ellipta NDA
20 February 2013
Regulatory briefs from GSK/Theravance, Allergan and Mylan
19 December 2012
Showing 1-5 of 5 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
